Pfizer withdraws application to sell drug without prescription after it hits opposition from government panel.
Original post by Lisa LaMotta and software by Elliott Back
Crude below $50 per barrel apt to dissuade production.
Original post by Lionel Laurent and Miriam Marcus and software by Elliott Back
Commercial mortgage problems are catalyst for stampede into Treasuries.
Original post by Lisa LaMotta and software by Elliott Back
Stocks dove again in the afternoon while Paulson further tackled the financial crisis.
Original post by Carl Gutierrez and software by Elliott Back
The pharma prevents Teva from selling a cheaper version of its drug Pulmicort–at least for now.
Original post by Lisa LaMotta and software by Elliott Back
Auto-finance firm seeks to become a bank so that it can access government funds — which it needs to become a bank.
Original post by Maurna Desmond and software by Elliott Back
Although the solar cell manufacturer saw rising demand in Q3, its profits slipped due to weak currency.
Original post by Ruthie Ackerman and software by Elliott Back
The aerospace and defense companies announced major job cuts to cope with the downturn.
Original post by Javier Espinoza and software by Elliott Back
Prince Alwaleed revealed plans to up his stake in the bank, but shares still headed south.
Original post by Miriam Marcus and software by Elliott Back
A wave of job cuts across the euro zone leave economists fearful about the coming year.
Original post by Javier Espinoza and software by Elliott Back
